A multicenter phase IV study to investigate the immunogenicity of recombinant human follicle-stimulating hormone and its impact on clinical outcomes in females undergoing controlled ovarian stimulation

• Main Authors: Abha Majumdar (Author), Le Hoang (Author), Ly T Loc (Author), Padma Srivastava (Author), Chitra Ramamurthy (Author), Ratnabali Chakravorty (Author), Yogeshwar S Nandanwar (Author), M D Rashmi (Author), Rahul V Mayekar (Author), Jayashree Sridhar (Author), Ganesh H Divekar (Author), James John (Author)
• Format: Book
• Published: Wolters Kluwer Medknow Publications, 2019-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Context: Therapeutic proteins can cause immune responses, which may have clinical implications. Aims: The aim of the study was to assess the immunogenicity of recombinant human follicle-stimulating hormone (r-hFSH), when used for controlled ovarian stimulation (COS). Settings and Design: Prospective...